FI20115576A0 - Menetelmä Alzheimerin taudin diagnoimiseksi - Google Patents

Menetelmä Alzheimerin taudin diagnoimiseksi

Info

Publication number
FI20115576A0
FI20115576A0 FI20115576A FI20115576A FI20115576A0 FI 20115576 A0 FI20115576 A0 FI 20115576A0 FI 20115576 A FI20115576 A FI 20115576A FI 20115576 A FI20115576 A FI 20115576A FI 20115576 A0 FI20115576 A0 FI 20115576A0
Authority
FI
Finland
Prior art keywords
disease
diagnosing alzheimer
alzheimer
diagnosing
Prior art date
Application number
FI20115576A
Other languages
English (en)
Swedish (sv)
Inventor
Matej Oreeic
Hilkka Soininen
Tuulia Hyoetylaeinen
Original Assignee
Teknologian Tutkimuskeskus Vtt Oy
Itae Suomen Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teknologian Tutkimuskeskus Vtt Oy, Itae Suomen Yliopisto filed Critical Teknologian Tutkimuskeskus Vtt Oy
Priority to FI20115576A priority Critical patent/FI20115576A0/fi
Publication of FI20115576A0 publication Critical patent/FI20115576A0/fi
Priority to JP2014514121A priority patent/JP2014521928A/ja
Priority to EP12735315.9A priority patent/EP2718729A1/en
Priority to KR1020147000722A priority patent/KR20140043782A/ko
Priority to PCT/FI2012/050571 priority patent/WO2012168561A1/en
Priority to US14/125,091 priority patent/US20140165700A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20115576A 2011-06-10 2011-06-10 Menetelmä Alzheimerin taudin diagnoimiseksi FI20115576A0 (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20115576A FI20115576A0 (fi) 2011-06-10 2011-06-10 Menetelmä Alzheimerin taudin diagnoimiseksi
JP2014514121A JP2014521928A (ja) 2011-06-10 2012-06-08 アルツハイマー病のリスクの増加を診断するための方法
EP12735315.9A EP2718729A1 (en) 2011-06-10 2012-06-08 Method of diagnosing on increased risk of alzheimer's disease
KR1020147000722A KR20140043782A (ko) 2011-06-10 2012-06-08 알츠하이머병의 증가된 위험도를 진단하는 방법
PCT/FI2012/050571 WO2012168561A1 (en) 2011-06-10 2012-06-08 Method of diagnosing on increased risk of alzheimer's disease
US14/125,091 US20140165700A1 (en) 2011-06-10 2012-06-08 Method of diagnosing on increased risk of alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20115576A FI20115576A0 (fi) 2011-06-10 2011-06-10 Menetelmä Alzheimerin taudin diagnoimiseksi

Publications (1)

Publication Number Publication Date
FI20115576A0 true FI20115576A0 (fi) 2011-06-10

Family

ID=44206787

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20115576A FI20115576A0 (fi) 2011-06-10 2011-06-10 Menetelmä Alzheimerin taudin diagnoimiseksi

Country Status (6)

Country Link
US (1) US20140165700A1 (fi)
EP (1) EP2718729A1 (fi)
JP (1) JP2014521928A (fi)
KR (1) KR20140043782A (fi)
FI (1) FI20115576A0 (fi)
WO (1) WO2012168561A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2592422A1 (en) * 2011-11-08 2013-05-15 Zora Biosciences OY Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
SG11201510701QA (en) * 2013-06-28 2016-01-28 Mcbi Inc Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
US20160195547A1 (en) * 2013-07-31 2016-07-07 Pharnext Diagnostic tools for alzheimer's disease
WO2015020523A1 (en) * 2013-08-07 2015-02-12 Stichting Vu-Vumc Biomarkers for early diagnosis of alzheimer's disease
EP3060305B1 (en) 2013-10-21 2019-04-03 Georgetown University Biomarkers for memory loss
EP3674711A3 (en) * 2014-07-01 2020-10-28 Steven W. Graves Biomarkers and methods for determining risk factors for alzheimer's disease
AU2015326756A1 (en) 2014-10-02 2017-05-11 Zora Biosciences Oy Methods for detecting ovarian cancer
WO2016124574A1 (en) 2015-02-03 2016-08-11 Pharnext Diagnostic tools for alzheimer's disease
WO2016187317A1 (en) 2015-05-18 2016-11-24 Georgetown University Metabolic biomarkers for memory loss
JP6870679B2 (ja) * 2016-07-08 2021-05-12 味の素株式会社 アルツハイマー型認知症の将来の発症リスクの評価方法
AU2019320619B2 (en) * 2018-10-30 2021-10-14 Kurume Research Park Co., Ltd. Disease risk assessment apparatus, disease risk assessment method, program, and food for dementia prevention
JP7379862B2 (ja) * 2019-05-09 2023-11-15 株式会社島津製作所 短鎖塩素化パラフィンの同族体の検出方法
US20220236294A1 (en) * 2019-06-12 2022-07-28 Huntington Medical Research Institutes Methods for Evaluation and Treatment of Alzheimer's Disease and Applications Thereof
CN111721859A (zh) * 2020-06-05 2020-09-29 珠海沅芷健康科技有限公司 基于超高效液相串联高分辨质谱的早期阿尔茨海默病鼠脂质组学分析方法及应用
CN111929430B (zh) * 2020-08-14 2021-09-17 宝枫生物科技(北京)有限公司 用于诊断认知障碍的生物标记物及其应用
CN111679018B (zh) * 2020-08-14 2020-11-20 宝枫生物科技(北京)有限公司 用于诊断认知障碍的生物标记物及其应用
JPWO2022210606A1 (fi) * 2021-03-29 2022-10-06

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002366555A1 (en) 2001-12-10 2003-06-23 Washington University Diagnostic for early stage alzheimer's disease
WO2006108051A2 (en) * 2005-04-05 2006-10-12 Neurodx, Llc Compositions and methods relating to alzheimer's disease
US8637321B2 (en) * 2005-10-24 2014-01-28 Duke University Lipidomics approaches for central nervous system disorders
US20120094315A1 (en) * 2008-12-09 2012-04-19 Stephanie Fryar-Williams Biomarkers for the diagnosis and/or prediction of susceptibility to mental and neurodegenerative disorders

Also Published As

Publication number Publication date
US20140165700A1 (en) 2014-06-19
KR20140043782A (ko) 2014-04-10
JP2014521928A (ja) 2014-08-28
WO2012168561A1 (en) 2012-12-13
EP2718729A1 (en) 2014-04-16

Similar Documents

Publication Publication Date Title
FI20115576A0 (fi) Menetelmä Alzheimerin taudin diagnoimiseksi
IL231620A0 (en) A method for diagnosing Alzheimer's disease
DK3448034T3 (da) Fremgangsmåde til at udlede bevægelsesinformation
ZA201404500B (en) Methods for diagnosing alzheimer's disease
FR2981857B1 (fr) Machine d'exercice
BR112013010351A2 (pt) aparelho de formação de imagem
FR3001166B1 (fr) Procede de rechargement d'une piece
FR2976914B1 (fr) Structure d'accrochage d'une turbomachine
BR112012022750A2 (pt) "método de produção de radionuclídeos"
BR112014001383A2 (pt) aparelho de formação de imagem
BR112013032352A2 (pt) doença tromboembólica
HK1179143A1 (zh) 用於對疾病進行成像的方法
GB201112246D0 (en) Diagnosis of alzheimer's disease
EP2742865A4 (en) METHOD FOR TESTING TOOTH TISSUE DISORDERS
IL231982A0 (en) A method for the diagnosis of Niemann-Pick disease
DK2729631T3 (da) Fremgangsmåde til at konstruere en tredimensionel opadvendt konveks ramme
DK3318881T3 (da) Fremgangsmåde til overvågning af Gaucher's sygdom
EP2791676A4 (en) PROCESS FOR THE DIAGNOSIS OF MORBUS ALZHEIMER
FI20115709A0 (fi) Menetelmä perinnöllisten syöpien diagnosointiin
FI20105078A0 (fi) Menetelmä tukkiyksilön tunnistamiseksi
FR2990242B1 (fr) Procede de demontage d'un turboreacteur
FR2987085B1 (fr) Procede de securisation du fonctionnement d'une turbomachine
FI20116047L (fi) Menetelmä terveyskortin hallinnoimiseksi
FR2988585B1 (fr) Plaque viscerale destinee a la coelioscopie
EP2615458A4 (en) METHOD FOR DIAGNOSIS OF ALZHEIMER WITH A BLOOD SOLUBLE GPVI

Legal Events

Date Code Title Description
FD Application lapsed